Oyster Point Pharma, Inc. Long-term Debt, Gross
Oyster Point Pharma, Inc. had Long-term Debt, Gross of $95.00 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentCarryingAmount · last filed 2022-11-10
- 2022-09-30: Long-term Debt, Gross $95.00M.
- 2022-06-30: Long-term Debt, Gross $95.00M.
- 2022-03-31: Long-term Debt, Gross $95.00M.
- 2021-12-31: Long-term Debt, Gross $95.00M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2022-09-30 | $95.00M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $95.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $95.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $95.00M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $45.00M 10-Q · filed 2021-11-04 |